Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial

Kan Yonemori, Shin Nishio, Shiro Suzuki, Kosei Hasegawa, Mayu Yunokawa, Satoshi Yamaguchi, Aikou Okamoto, Kazuto Nakamura, Shoji Kamiura, Keiichi Fujiwara, Noriyuki Katsumata, Hiroaki Kobayashi, Tomoka Usami, Ayako Mochizuki, Kazuhiro Takehara, Elizabeth Whalley, Hidehisa Noguchi, Ibrahima Soumaoro, Brian Slomovitz, Ignace Vergote

Open source

DOI: 10.1016/j.ijgc.2025.104450
Published: 2026-04
Container: International Journal of Gynecological Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijgc.2025.104450,
  title = {Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial},
  author = {Kan Yonemori and Shin Nishio and Shiro Suzuki and Kosei Hasegawa and Mayu Yunokawa and Satoshi Yamaguchi and Aikou Okamoto and Kazuto Nakamura and Shoji Kamiura and Keiichi Fujiwara and Noriyuki Katsumata and Hiroaki Kobayashi and Tomoka Usami and Ayako Mochizuki and Kazuhiro Takehara and Elizabeth Whalley and Hidehisa Noguchi and Ibrahima Soumaoro and Brian Slomovitz and Ignace Vergote},
  year = {2026},
  journal = {International Journal of Gynecological Cancer},
  doi = {10.1016/j.ijgc.2025.104450},
  url = {https://doi.org/10.1016/j.ijgc.2025.104450}
}

RIS

TY  - JOUR
TI  - Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial
AU  - Kan Yonemori
AU  - Shin Nishio
AU  - Shiro Suzuki
AU  - Kosei Hasegawa
AU  - Mayu Yunokawa
AU  - Satoshi Yamaguchi
AU  - Aikou Okamoto
AU  - Kazuto Nakamura
AU  - Shoji Kamiura
AU  - Keiichi Fujiwara
AU  - Noriyuki Katsumata
AU  - Hiroaki Kobayashi
AU  - Tomoka Usami
AU  - Ayako Mochizuki
AU  - Kazuhiro Takehara
AU  - Elizabeth Whalley
AU  - Hidehisa Noguchi
AU  - Ibrahima Soumaoro
AU  - Brian Slomovitz
AU  - Ignace Vergote
PY  - 2026
JO  - International Journal of Gynecological Cancer
DO  - 10.1016/j.ijgc.2025.104450
UR  - https://doi.org/10.1016/j.ijgc.2025.104450
ER  -

APA

Yonemori, K., Nishio, S., Suzuki, S., Hasegawa, K., Yunokawa, M., Yamaguchi, S., Okamoto, A., Nakamura, K., Kamiura, S., Fujiwara, K., Katsumata, N., Kobayashi, H., Usami, T., Mochizuki, A., Takehara, K., Whalley, E., Noguchi, H., Soumaoro, I., Slomovitz, B., & Vergote, I. (2026). Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial. International Journal of Gynecological Cancer. https://doi.org/10.1016/j.ijgc.2025.104450

Source records

crossref · retrieved 2026-09-26T04:49:59.397Z